Menopausal vasomotor symptoms - A review of causes, effects and evidence-based treatment options

被引:0
|
作者
Bachmann, GA
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Obstet & Gynecol, New Brunswick, NJ 08901 USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA
关键词
menopause; vasomotor system; flushing;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Vasomotor symptoms are the most common medical complaint of perimenopausal and postmenopausal women. Frequent vasomotor symptoms can be disabling, affecting a woman's social life, psychological health, sense of well-being and ability to work. Women with hot flushes are more likely to experience disturbed sleep, depressive symptoms and significant reductions in quality of life as compared to asymptomatic women. Despite the prevalence and impact of these symptoms, the pathophysiology of hot flushes is unclear; however, estrogen withdrawal clearly plays an important role. It is postulated that declining estrogen concentrations may lead to changes in brain neurotransmitters and instability in the hypothalamic thermoregulatory center. The most effective therapy for relieving vasomotor symptoms and reducing their impact on quality of life is hormone therapy. Other options for women who decline hormone therapy include selective serotonin reuptake inhibitors and related agents. Most herbal therapies that have been evaluated in placebo-con trolled trials have shown no clinically significant benefit.
引用
收藏
页码:155 / 165
页数:11
相关论文
共 50 条
  • [21] Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review
    Jacobs, Anja
    Wegewitz, Uta
    Sommerfeld, Christine
    Grossklaus, Rolf
    Lampen, Alfonso
    MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 (09) : 1084 - 1097
  • [22] Phytoestrogen Treatment for Menopausal Vasomotor Symptoms after Breast Cancer
    Vogel, Marie
    Franik, Sebastian
    Kiesel, Ludwig
    BREAST CARE, 2023, 18 (03) : 158 - 162
  • [23] Efficacy and safety of desvenlafaxine succinate for treatment of menopausal vasomotor symptoms
    Gass, Margery
    Olivier, Sophie
    Constantine, Ginger
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 75S - 75S
  • [24] Management of menopausal symptoms in patients with breast cancer: an evidence-based approach
    Hickey, M
    Saunders, CM
    Stuckey, BGA
    LANCET ONCOLOGY, 2005, 6 (09): : 687 - 695
  • [25] Biologic treatment options for pityriasis rubra pilaris: An evidence-based systematic review
    Sood, Siddhartha
    Akuffo-Addo, Edgar
    Yeung, Jensen
    Mufti, Asjandyar
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1306 - 1308
  • [26] Current and emerging evidence-based treatment options in chronic migraine: a narrative review
    Agostoni, Elio Clemente
    Barbanti, Piero
    Calabresi, Paolo
    Colombo, Bruno
    Cortelli, Pietro
    Frediani, Fabio
    Geppetti, Pietrangelo
    Grazzi, Licia
    Leone, Massimo
    Martelletti, Paolo
    Pini, Luigi Alberto
    Prudenzano, Maria Pia
    Sarchielli, Paola
    Tedeschi, Gioacchino
    Russo, Antonio
    JOURNAL OF HEADACHE AND PAIN, 2019, 20 (01):
  • [27] Current and emerging evidence-based treatment options in chronic migraine: a narrative review
    Elio Clemente Agostoni
    Piero Barbanti
    Paolo Calabresi
    Bruno Colombo
    Pietro Cortelli
    Fabio Frediani
    Pietrangelo Geppetti
    Licia Grazzi
    Massimo Leone
    Paolo Martelletti
    Luigi Alberto Pini
    Maria Pia Prudenzano
    Paola Sarchielli
    Gioacchino Tedeschi
    Antonio Russo
    The Journal of Headache and Pain, 2019, 20
  • [28] Central Retinal Vein Occlusion: A Review of Current Evidence-based Treatment Options
    Patel, Amy
    Nguyen, Christine
    Lu, Stephanie
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2016, 23 (01) : 44 - 48
  • [29] Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
    Umland, Elena M.
    Falconieri, Laura
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2012, 4 : 305 - 319
  • [30] Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms
    Pinkerton, JoAnn, V
    Redick, Dana L.
    Homewood, Laura N.
    Kaunitz, Andrew M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (11): : E1448 - E1449